Guided Booth and Poster Tours

The Booth and Poster Tours program is designed to facilitate meaningful interactions among attendees in small groups, fostering the exchange of intellect and experiences. This initiative holds particular value for first-time MSACL attendees, providing them with the chance to connect with colleagues who share similar interests. Additionally, it serves as a valuable opportunity for early-career attendees to approach, interact, and build connections with mid- to late-career professionals within the community.

Booth and Poster Tours: Guides browse booths or view posters as they normally would, but with one or more participants along to observe, join discussions and learn from the experience.

You can sign up at the conference to participate in Guided Activities (i.e., Booth Tour, Poster Tour).

	Jessica Colón-Franco, PhD Cleveland Clinic Foundation	Poster Tour 3 on Thursday @ 9:15
Dr Jessica M Colón-Franco is Section Head of Clinical Biochemistry and Director of the Special Chemistry Laboratory at Cleveland Clinic, and adjunct faculty at Cleveland State University in Cleveland, OH. In her current role, Jessica provides strategic, clinical and scientific direction to the clinical laboratories in the section. Previously, Jessica was Director of Chemistry, Toxicology and Point-of-Care at Wisconsin Diagnostic Laboratories and Associate Professor at the Medical College of Wisconsin in Milwaukee, WI. Jessica obtained her bachelor’s degree in industrial biotechnology from the University of Puerto Rico at Mayagüez, Puerto Rico and her doctorate degree in Biochemistry and Molecular Biology from the Mayo Graduate School, College of Medicine in Rochester, MN. She completed a fellowship in Clinical Chemistry at Vanderbilt University Medical Center in Nashville, TN. Jessica is a diplomate of the American Board of Clinical Chemistry, fellow of the AACC Academy and is a member of several laboratory medicine associations, where she has served in various committee roles. Jessica’s interests are focused on endocrinology, therapeutic drug monitoring and toxicology, and inflammatory biomarkers.
	Robert Fitzgerald, PhD, DABCC University of California San Diego	Poster Tour 2 on Wednesday @ 14:30 Poster Tour 3 on Thursday @ 9:15
Robert L. Fitzgerald, PhD, DABCC Dr. Fitzgerald received his BS degree in Chemistry at Loyola College of Maryland, and his PhD in Pharmacology/Toxicology at the Medical College of Virginia/Virginia Commonwealth University. After two and a half years as a forensic toxicologist for the State of Virginia, he took a position as the Director of the Mass Spectrometry Laboratory at the San Diego VA Hospital. Currently, Dr. Fitzgerald is a Professor in the Department of Pathology at the University of California, San Diego where he is the director of the toxicology laboratory and associate director of the clinical chemistry laboratory. He is board certified in toxicology and clinical chemistry by the American Board of Clinical Chemistry. He is the director of the clinical chemistry fellowship at UCSD.
	Elizabeth Frank, PhD University of Utah Health / ARUP Laboratories	Booth Tour on Tuesday @ 20:00 Poster Tour 2 on Wednesday @ 14:30 Poster Judge on March 2-10 (PDF Review) & 20-21 (Interview Finalists) @ Time TBD
Elizabeth L. Frank, PhD, is a professor of pathology at the University of Utah School of Medicine and a medical director at ARUP Laboratories, a national reference laboratory operated by the University of Utah, in Salt Lake City. She is certified as a clinical chemist by the American Board of Clinical Chemistry and is a fellow of the AACC Academy. Dr. Frank's clinical and scientific interests are focused on measurement of biogenic amines, porphyrins, and vitamins using HPLC and LC-MS/MS; determination of calculi composition using FTIR; biochemical assessment of nephrolithiasis risk; and use of laboratory test results to evaluate health status.
	Joshua Hayden, PhD, DABCC, FACB Cleveland Clinic	Booth Tour on Tuesday @ 20:00 Poster Tour 3 on Thursday @ 9:15 Poster Judge on March 2-10 (PDF Review) & 20-21 (Interview Finalists) @ Time TBD
Joshua is currently the Section Head of Clinical Biochemistry at Cleveland Clinic. He earned his PhD in chemistry from Carnegie Mellon University. He conducted postdoctoral research at Massachusetts Institute of Technology before completing a two-year clinical chemistry fellowship at University of Washington and 4 years as Assistant Professor at Weill Medical College. Joshua has special expertise developing and overseeing mass spectrometry assays in the clinical laboratory.
	David Herold, MD, PhD MSACL, University of California San Diego and VA San Diego Medical Center	Booth Tour on Tuesday @ 20:00
David Herold received his BS (1966) in Chemistry from Tulane University. He completed his MA (1972) in Chemistry at the University of North Carolina-Chapel Hill, served 5 years in the USAF, received his MD (1979) and PhD (1982) at the University of Utah and then completed a Clinical Pathology residency (1982) at the University of Virginia. In 1982 he joined the University of Virginia faculty. In 1991 he moved to the University of California, San Diego and is now Professor of Pathology. He has authored and co-authored over 80 scientific publications and presented at numerous international scientific conferences. Inspired by the 2007 ASMS Asilomar conference on clinical mass spectrometry, Dr. Herold co-founded MSACL. From 2008 to the present, he has served as CEO, Executive Board Chair and Global Scientific Coordinator of MSACL. MSACL's mission is to further the accumulation and sharing of expertise in mass spectrometry and other advanced technologies in the clinical laboratory through educational advancement. MSACL will continue building the foundation for the adoption of technology in the clinical laboratory, including data science, based on the belief that this will provide more accurate, precise and timely laboratory results at lower overall costs that will result in better patient care and outcomes.
	Claire Knezevic, PhD Lurie Childrens Hospital	Booth Tour on Tuesday @ 20:00 Poster Judge on March 2-10 (PDF Review) & 20-21 (Interview Finalists) @ Time TBD
Dr. Claire Knezevic is a clinical chemist in the Department of Pathology and Laboratory Medicine at Lurie Children's Hospital with a focus on chemistry, point-of-care testing, quality improvement, drug monitoring, and personalized medicine. She is an Associate Professor in Northwestern's Feinberg School of Medicine in the Department of Pathology. Her interests include all things small molecule, from toxicology to therapeutic drug monitoring and their impacts on clinical care.
	Guinevere Lageveen-Kammeijer, PhD University of Groningen	Poster Tour 2 on Wednesday @ 14:30 Poster Judge on March 2-10 (PDF Review) & 20-21 (Interview Finalists) @ Time TBD
Dr. Guinevere Lageveen-Kammeijer is an Assistant Professor in the Analytical Biochemistry group at the University of Groningen, within the Groningen Research Institute of Pharmacy. She holds a BSc in Biotechnology - Forensic Sciences from the University of Applied Sciences van Hall Larenstein, Leeuwarden, and an MSc in Analytical Chemistry from VU University, Amsterdam. Her research interests were ignited during her MSc internship, where she focused on separation techniques coupled with mass spectrometry. Guinevere earned her PhD in Clinical Glycomics from the Leiden University Medical Center in 2019 under the supervision of Prof. Manfred Wuhrer. Her thesis developed small-scale sample preparation workflows using capillary electrophoresis (CE) and mass spectrometry (MS/MS) to analyze glycans, glycopeptides, and glycoproteins, with applications in biomarker discovery and biopharmaceutical characterization. She continued her research as a post-doctoral researcher at the same institution before expanding her expertise with a visit to Northeastern University, Boston, in 2017, where she focused on protein charge and proteoform heterogeneity. In 2022, Guinevere began her tenure-track assistant professorship at the University of Groningen, where she works on advancing glyco(proteo)mic techniques, particularly in single-cell glycomic analysis. Her research includes expanding the mass spectrometry-based glycosylation assay for prostate-specific antigen (PSA), a key biomarker for prostate cancer, and exploring the in-depth analysis of glycans and glycoproteins for biomarker discovery in other diseases and biopharmaceutical characterization. Guinevere’s contributions have been recognized through funding such as the Investigator Sponsored Research grant from Astellas (2019) and the prestigious NWO VENI grant (2023). She is actively involved in the scientific community, serving on the Scientific Omics Committee for MSACL. Guinevere is passionate about promoting the importance of glycosylation in biomarker research, aiming to bridge the gap between researchers and clinical professionals to improve biomarker translation to the clinic.
	Gwen McMillin, PhD NMS Labs	Poster Tour 3 on Thursday @ 9:15
My background originates in pharmacology, with particular emphasis on pre-clinical development of anticonvulsant drugs and academics. I transitioned to clinical diagnostics in 1996 and spent nearly 30 years working in various capacities at ARUP Laboratories including responsibilities and oversight relative to clinical applications of mass spectrometry, clinical toxicology, trace and toxic elements, and pharmacogenomics, while maintaining my involvement in academics at the University of Utah. In 2025 I joined NMS Labs where I am excited to continue my journey in clinical applications of mass spectrometry, but to also expand my horizons in a new environment!
	Alejandro Molinelli, PhD St. Jude Children's Research Hospital	Poster Tour 3 on Thursday @ 9:15
Alejandro Molinelli, PhD is Director of the Clinical Pharmacokinetics Laboratory in the Department of Pharmacy and Pharmaceutical Sciences at St. Jude Children's Research Hospital. His duties include clinical consultancy, technical and regulatory oversight of the laboratory, and method development and validation. Dr. Molinelli also serves as a Clinical Chemist Consultant with the Department of Pathology at St. Jude. Prior to joining St. Jude Dr. Molinelli completed a Clinical Chemistry Fellowship at the University of Washington in Seattle; obtained his PhD in toxicology at the University of North Carolina at Chapel Hill; and bachelor’s and master’s degrees in biology and biochemistry at the University of Puerto Rico. Dr. Molinelli’s professional interests include therapeutic drug monitoring, clinical toxicology, and quality improvement.
	Laura Sanchez, PhD University of California, Santa Cruz	Booth Tour on Tuesday @ 20:00 Poster Tour 2 on Wednesday @ 14:30 Poster Tour 3 on Thursday @ 9:15 Poster Judge on March 2-10 (PDF Review) & 20-21 (Interview Finalists) @ Time TBD
Laura started her independent lab in the Fall of 2015 at the University of Illinois at Chicago in the Department of Pharmaceutical sciences. The lab relocated to the University of California, Santa Cruz Department of Chemistry and Biochemistry in January 2021. Her team specializes in using and adapting imaging mass spectrometry and tandem mass spectrometry for small molecule analyses in complex systems. Laura was a K12 BIRCWH Scholar (2016-2017) which supported the translation of the techniques to women's health. She was the Rising Star in the Life Sciences in 2019 at UIC.
	Raymond Suhandynata, PhD DABCC University of California, San Diego	Booth Tour on Tuesday @ 20:00 Poster Tour 2 on Wednesday @ 14:30
Dr. Suhandynata is an Assistant Professor at the University of California San Diego with appointments in the Skaggs School of Pharmacy and Department of Pathology. He serves as the Associate Laboratory Director for the CMCR reference laboratory and the Associate Director of the UCSD ComACC clinical chemistry fellowship. He completed his Clinical Chemistry fellowship training at the UC San Diego Center for Advanced Laboratory Medicine, under the direction of Dr. Robert Fitzgerald. He has extensive experience with applications of mass spectrometry in research, pre-clinical, and clinical laboratories. Areas of interest include phospho-proteomics to identify novel kinase targets by LC-MS/MS, SUMO proteomics to identify cellular signals involved in chromosome segregation, utilization of MALDI-TOF MS in to identify antibiotic resistant bacteria in the clinical specimens, and development of targeted LC-MRM/PRM assays for small molecules and peptides. Addtionally, he as made significant contributions during the COVID-19 pandemic, validating several COVID-19 serology LDTs at UCSD Health.